Education
About Us
Working with TipRanks
Follow Us
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 502.08M | $ 221.90M | $ 9.30M | $ 77.65M | $ 69.72M |
| Gross Profit | $ 473.81M | $ 218.02M | $ 6.86M | $ 74.21M | $ 66.60M |
| Operating Income | $ -569.09M | $ -592.97M | $ -607.37M | $ -512.20M | $ -576.63M |
| EBITDA | $ -672.88M | $ -436.83M | $ -565.47M | $ -397.44M | $ -533.83M |
| Net Income | $ -729.31M | $ -535.76M | $ -643.20M | $ -481.18M | $ -562.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 587.48M | $ 681.10M | $ 434.88M | $ 471.92M | $ 836.66M |
| Total Assets | $ 936.02M | $ 919.34M | $ 546.38M | $ 623.04M | $ 1.01B |
| Total Debt | $ 10.00M | $ 1.73B | $ 1.74B | $ 1.72B | $ 1.73B |
| Net Debt | $ -560.12M | $ 1.05B | $ 1.36B | $ 1.35B | $ 1.33B |
| Total Liabilities | $ 3.01B | $ 2.38B | $ 1.89B | $ 1.87B | $ 1.88B |
| Stockholders' Equity | $ -2.08B | $ -1.47B | $ -1.35B | $ -1.25B | $ -870.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -447.01M | $ -521.66M | $ -529.03M | $ -425.81M | $ -546.18M |
| Operating Cash Flow | $ -445.91M | $ -520.73M | $ -527.72M | $ -419.49M | $ -497.93M |
| Investing Cash Flow | $ -24.49M | $ 60.78M | $ 54.03M | $ 453.15M | $ -200.83M |
| Financing Cash Flow | $ 359.29M | $ 748.46M | $ 451.54M | $ -13.13M | $ 736.45M |